HVCN1 and neoplasm: We encourage investigators to inhibit Hv1 with zinc ion, especially in vivo, as it is simpler, and promotes T lymphocyte signaling and proliferation, it could be further efficient in tumor treatment, in comparison with specific Hv1 channel inhibitors (ClGBI).